- Forums
- ASX - By Stock
- Ann: ALA-101 confers survival benefit in leukemia model
Drifting down again. Just as I was getting excited.
Featured News
Add ALA (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.015(7.89%) |
Mkt cap ! $216.5M |
Open | High | Low | Value | Volume |
19.5¢ | 20.5¢ | 19.5¢ | $342.9K | 1.742M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 268422 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 439671 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 268422 | 0.195 |
11 | 564541 | 0.190 |
5 | 374767 | 0.185 |
9 | 350307 | 0.180 |
14 | 723391 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 439671 | 4 |
0.210 | 973742 | 7 |
0.215 | 100000 | 1 |
0.220 | 509800 | 6 |
0.225 | 407286 | 7 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online